Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
2'-fucosyllactose (1 trial)
89zr-j591 (1 trial)
glipizide (glucotrol) (1 trial)
glucose (1 trial)
sitagliptin (januvia) (2 trials)
ethanol (1 trial)
Colitis, Ulcerative (Phase 2)
Crohn Disease (Phase 2)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Inflammatory Bowel Diseases (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (6 total)